EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BioSig Technologies's enterprise value is $192.17 Mil.
BioSig Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $-12.90 Mil. Therefore, BioSig Technologies's EV-to-EBITDA for today is -14.89.
The historical rank and industry rank for BioSig Technologies's EV-to-EBITDA or its related term are showing as below:
BSGM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -16.59 Med: -1.25 Max: -0.11
Current: -14.89
During the past 12 years, the highest EV-to-EBITDA of BioSig Technologies was -0.11. The lowest was -16.59. And the median was -1.25.
BSGM's EV-to-EBITDA is ranked worse than 100% of 497
companies
in the Medical Devices & Instruments industry
Industry Median: 15.56
vs BSGM: -14.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
BioSig Technologies EV-to-EBITDA Historical Data
The historical data trend for BioSig Technologies's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioSig Technologies's EV-to-EBITDA
For the Medical Devices subindustry, BioSig Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioSig Technologies's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BioSig Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BioSig Technologies's EV-to-EBITDA falls into.
BioSig Technologies's current Enterprise Value is $192.17 Mil.
BioSig Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.90 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BioSig Technologies's PE Ratio (TTM) for today is calculated as:
BioSig Technologies's share price for today is $7.14.
BioSig Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.590.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Thank you for viewing the detailed overview of BioSig Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
BioSig Technologies Inc is a medical device technology company with an advanced digital signal processing technology platform, the PURE EP Platform (PURE EP), that delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. The PURE EP Platform enables electrophysiologists to acquire raw signal data in real-time, absent unnecessary noise or interference, to maximize procedural success and minimize unnecessary inefficiencies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BSGM has been successfully added to your 